HSIC Stock Chart & Stats
$1523.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1523.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,311.03 - $1,523.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$170.29B
Enterprise Value$13.54K
Total Cash (Recent Filing)$138.00M
Total Debt (Recent Filing)$3.75B
Price to Earnings (P/E)25.7
Beta<0.01
Next Earnings
Aug 04, 2026EPS Estimate
21.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.34
Shares Outstanding113,916,756
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio3.23
Price to Book (P/B)2.83
Price to Sales (P/S)0.70
P/FCF Ratio16.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,526.71Price Target Upside0.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)93.25
Revenue Forecast (FY)$239.78B
Bulls Say, Bears Say
Bulls Say
Scale & Diversified DistributionHenry Schein's broad distribution footprint and diversified product mix (consumables, equipment, technology, services) creates recurring, high-frequency revenue from office-based clinicians. Scale and supplier relationships support resilience, steady reorder streams, and bargaining power that sustain cash generation over time.
Cloud & Software MomentumRapid growth in cloud and software subscribers builds a recurring, higher-margin revenue cohort that improves revenue visibility and reduces reliance on lower-margin product sales. As software and value-added services approach greater than ~50% of operating income, structural profitability and customer stickiness should strengthen long-term cashflow quality.
E‑commerce PenetrationHigh e-commerce adoption centralizes ordering, reduces fulfillment friction, and enables better pricing, mix and data-driven cross-sell. Persistent platform penetration can lower cost-to-serve, increase repeat purchase rates, and boost gross-profit capture, supporting durable margin improvement as digital sales scale.
Bears Say
Elevated LeverageMaterially higher debt increases financial risk and reduces strategic flexibility. Elevated leverage makes the company more sensitive to interest-cost rises or cyclical downturns, constrains capacity for opportunistic M&A or buybacks, and increases the importance of consistent cash generation to meet obligations.
Sustained Margin CompressionStructural margin erosion limits earnings power despite revenue growth. Competitive price pressure on digital equipment and a mix shift toward lower‑margin value implants reduce gross and net margins. Until value‑creation initiatives and pricing/mix improvements fully offset these trends, profitability will remain constrained.
Weaker & Volatile Cash FlowDeclining and more volatile operating and free cash flow undermines the firm's ability to de‑lever and fund transformation plans. Seasonal negative cash quarters, restructuring costs, and working capital swings increase execution risk and may delay the firm's ability to convert EBITDA gains into durable balance‑sheet improvement.
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $1311.03 and its highest was $1523.00 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $170.29B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Aug 04, 2026 which is in 4 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on May 05, 2026. The company reported $23.021 earnings per share for the quarter, beating the consensus estimate of $21.242 by $1.779.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 21.61.
How many shares outstanding does Henry Schein have?
Henry Schein has 113,916,756 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $23.021 in its last earnings report, beating expectations of $21.242. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in MX:HSIC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Henry Schein Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,526.71 (0.24% Upside)
$1,526.71 (0.24% Upside)
Blogger Sentiment
Bullish
MX:HSIC Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $691.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
HSIC Company Deck
HSIC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial positives — solid revenue growth (+6.3% total, 2.5% internal), non-GAAP margin expansion (+28 bps), adjusted EBITDA growth (+11.6%), cloud/customer momentum (+25% cloud subscribers), rapid e-commerce adoption (80%+ U.S. dental e-commerce), and an explicit multi-year value-creation plan with a $125 million 2026 run-rate target and a >$200 million longer-term target. Offsetting these were manageable but important risks: a Q1 GAAP margin dip and slight GAAP net income decline, negative Q1 operating cash flow (seasonal), softness in medical diagnostics due to a light flu season, digital equipment ASP pressure, restructuring costs ($12M in Q1), and exposure to rising oil/freight costs. Overall, the positives (growth, margin expansion on a non-GAAP basis, technology and e-commerce traction, and clear cost-transformation initiatives) materially outweigh the near-term headwinds and execution costs, supporting an optimistic outlook grounded with prudent caveats around macro and timing of savings.View all MX:HSIC earnings summariesHSIC Revenue Breakdown
84.48% Global Distribution and Value-Added Services
11.71% Global Specialty Products
5.12% Global Technology
-1.31% Eliminations

HSIC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$1,526.71
▲(0.24% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month









